We design and support RNA-seq and proteomics studies to discover novel biomarkers. We also re-analyze existing data with advanced statistical models and can build custom databases and atlases fit for your needs. When we perform the analysis, we provide clear deliverables that explain what the data support and what they do not.
We develop strategies to establish the translational value of preclinical biomarkers and offer services to design, procure, and validate custom cell models and analytical assays. We can also help prioritize indications and patient populations where strong biomarker evidence could support an early clinical development strategy.
Our custom software tools can answer specific scientific and legal questions about therapeutic antibody patents and families. We can analyze when and where sequences were first disclosed, what is claimed versus disclosed, and how claims and sequences evolve across continuations. We deliver reports that summarize findings and track exactly where they come from to accelerate legal research.
Start a conversation
Send a brief, non-confidential description of the problem, the relevant data sources, and the kind of support you are considering.
We can start with a free initial call to understand the question and what would be useful to answer it.